HealthEquity Inc Stock News

HQY remains a buy for long-term investors, with exceptional economics, high margins, and capital-light growth despite recent multiple contraction. Q1 FY26 results showed strong revenue and earnings growth, margin expansion, and operating leverage, confirming the business is scaling efficiently. The recurring, asset-linked revenue model benefits from secular healthcare tailwinds, high switching ...

Industry Leader's HSAnswers Wins Multiple Awards to Transform Complex Healthcare Benefits Information to Accessible and Reliable Intel For Millions Industry Leader's HSAnswers Wins Multiple Awards to Transform Complex Healthcare Benefits Information to Accessible and Reliable Intel For Millions

Funding supports 20 nonprofit organizations focused on physical and mental health, financial literacy, and basic needs as the foundation grows and welcomes a new leader Funding supports 20 nonprofit organizations focused on physical and mental health, financial literacy, and basic needs as the foundation grows and welcomes a new leader

Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses, guidance cuts, and Medicare Advantage mispricing, despite its long-term potential to restore profitability. Thermo Fisher and argenx detracted from performance amid macro headwinds and lower-than...

DRAPER, Utah, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA") custodian, today announced plans to release its second quarter of fiscal 2026 financial results following the close of regular stock market trading hours on Tuesday, September 2, 2025. Following the news release, HealthEquity man...

Growth stocks can create significant returns for investors, but what are they and how do you find the best ones? We take a closer look here.

HealthEquity (HQY 9.01%) reported fiscal 2026 first quarter (ended April 30, 2025) earnings on June 3, 2025, delivering 15% year-over-year revenue growth and raising full-year guidance. Key milestones included a 19% increase in adjusted EBITDA to $140.2 million, sharp reductions in quarterly fraud costs, and notable progress advancing both AI-enabled member experiences and regulatory engagement...

HealthEquity, Inc. (NASDAQ:HQY ) Q1 2026 Earnings Conference Call June 3, 2025 4:30 PM ET Company Participants James M. Lucania - CFO & Executive VP Jon Kessler - Former Director & Special Advisor Richard Putnam - Vice President of Investor Relations Scott R.